OrbiMed, a healthcare-focused investment firm, has raised $431.53 million for its third Asia fund, according to an SEC filing. The target is $450 million.
OrbiMed Closes $431.53M for Third Asia Fund
-
Sponsored -
Agency/Corporate Program 
